AI-powered model predicts EGFR mutations from H&E-stained slides, demonstrating robust performance across diverse clinical ...
The firm's next-generation pancreatic cancer test looks for five biomarkers that are indicative of early-stage disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback